GENOMMA LAB INTERNACIONAL SAB (LABB.MX) Financials
LABB.MX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 22.1 billion | 11.5 billion |
2023-06-30 | 21.7 billion | 11.2 billion |
2023-03-31 | 21.8 billion | 11.5 billion |
LABB.MX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 611.3 million | ? |
2023-06-30 | 402.1 million | ? |
2023-03-31 | 234.9 million | ? |
LABB.MX Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | -115.5 million |
2023-09-30 | 370.7 million |
2023-06-30 | 417.4 million |
2023-03-31 | 358.0 million |
LABB.MX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | - |
2023-09-30 | - | - | - |
2023-06-30 | - | - | - |
2023-03-31 | - | - | - |
LABB.MX Shares Outstanding
LABB.MX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | - | - | - |
2023-09-30 | 50.5 million | - | 1.8 billion | - |
2023-06-30 | 45.6 million | - | 1.8 billion | - |
2023-03-31 | 83.1 million | - | 1.7 billion | - |
LABB.MX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | 4.4 billion | 1.7 billion |
2023-06-30 | 4.4 billion | 1.7 billion |
2023-03-31 | 4.2 billion | 1.6 billion |
LABB.MX
Price: MX$16.90
52 week price:
5-year range yield:
Forward Dividend Yield: 4.64%
Payout Ratio: 51.94%
Payout Ratio Range:
Dividend Per Share: 0.78 MXN
Earnings Per Share: 1.51 MXN
P/E Ratio: 11.25
Exchange: MEX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 16.4 billion
Average Dividend Frequency: 2
Years Paying Dividends: 3